The processes around vaccine licensure today are still built on a shared core: robust evidence for quality, safety, and efficacy, demonstrated through standardized preclinical testing, phased clinical trials, and...
During the COVID-19 pandemic, mRNA vaccines came to the rescue, developed in record time and saving lives worldwide. Harvard Medical School researchers at Boston Children’s Hospital have now developed two technologies...
An international group of researchers specialising in human challenge studies is embarking on a project to develop advanced virus-blocking vaccines. The global consortium will lay the crucial groundwork needed to...